This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Artemis Diagnostics Announces Company Name Change To Lightpoint Medical, And Appointment Of David Ford To The Board Of Directors

RICKMANSWORTH, England, January 25, 2013 /PRNewswire/ --

Artemis Diagnostics Ltd, a developer of innovative imaging technologies for cancer surgery, announced today that the company has changed its name to Lightpoint Medical Ltd. The name change reflects the company's focus on the medical device sector.

The company also announced the appointment of David Ford to its Board of Directors. Mr Ford has more than 20 years' experience in the medical device industry including 12 years at board level. Formerly the Executive Director of BSI Group, he was responsible for the worldwide Healthcare and Testing activity for the British Standards Institution. During David's tenure, BSI became the leading certification and accreditation body to the global healthcare industry incorporating two notified bodies in support of the European Medical Devices Directive. David is currently a Non-Executive Director at TrusTECH, an innovation gateway within the NHS. He has represented the United Kingdom at the World Health Organization, the FDA and the European Commission in developing policy for medical devices and medical device regulation. David was trained at St. Mary's Hospital Medical School, London and at Brunel University, and holds an MBA from INSEAD.

Dr David Tuch, CEO of Lightpoint Medical, commented "We are delighted to welcome David Ford to our Board of Directors. David's extensive experience in medical device regulations, marketing, and sales will bring significant value to Lightpoint Medical. We look forward to his contributions to the company as we advance our imaging technology to the market."

About Lightpoint Medical

Lightpoint Medical is an early-stage medical device company seeking to improve health outcomes for cancer patients through image-guided surgery. The company's molecular imaging technology, based on Cerenkov Luminescence Imaging, has the potential to detect cancer in real-time during surgery, providing more accurate cancer treatment while sparing healthy tissue.

For more information contact David Tuch on +44-(0)7725-832-539, info@lightpointmedical.com or visit  http://www.lightpointmedical.com.

SOURCE Lightpoint Medical

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,122.01 +15.31 0.09%
S&P 500 2,000.12 +0.10 0.00%
NASDAQ 4,569.6210 -1.0160 -0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs